Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
626 - 650 of 8587 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2023
  • 2018
  • 2016
  • 2016
  • 2019
  • 2019
  • 2023
  • 2019
  • 2022
  • 2014
  • 2023
  • 2023
  • 2019
  • 2014
  • 2019
  • 2011
  • 2023
  • 2017
  • 2020
  • 2021
  • 2007
  • 2020
  • 2018
  • PAKs in the brain: Function and dysfunction
    2018
    Summary Details
    RESTRICTED
    Title: PAKs in the brain: Function and dysfunction
    Author(s): Laura Civiero, Elisa Greggio
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Vol: 1864
    Issue #: 2
    Start Page: 444
    End Page: 453
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2017.11.005
    Best OA location URL: https://doi.org/10.1016/j.bbadis.2017.11.005
    Citation Count: 40
  • Review: Somatic mutations in neurodegeneration
    2018
    Summary Details
    RESTRICTED
    Title: Review: Somatic mutations in neurodegeneration
    Author(s): Melissa Leija‐Salazar, Caitlin E. Piette, Christos Proukakis
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Vol: 44
    Issue #: 3
    Start Page: 267
    End Page: 285
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12465
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12465
    Citation Count: 73
  • Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid
    2023
    Summary Details
    RESTRICTED
    Title: Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid
    Author(s): Luis Concha‐Marambio, Sandra Pritzkow, Mohammad Shahnawaz, Carly M. Farris, Claudio Soto
    Journal Name: Nature Protocols
    Publisher: Springer Science and Business Media LLC
    Vol: 18
    Issue #: 4
    Start Page: 1179
    End Page: 1196
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41596-022-00787-3
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561622
    Citation Count: 35
  • Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options
    2018
    Summary Details
    RESTRICTED
    Title: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options
    Author(s): Veronica Francardo
    Journal Name: Behavioural Brain Research
    Publisher: Elsevier BV
    Vol: 352
    Issue #:
    Start Page: 142
    End Page: 150
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014
    Best OA location URL:
    Citation Count: 20
  • Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases
    2016
    Summary Details
    RESTRICTED
    Title: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases
    Author(s): Zhentao Zhang, Manling Xie, Keqiang Ye
    Journal Name: Expert Opinion on Therapeutic Targets
    Publisher: Informa UK Limited
    Vol: 20
    Issue #: 10
    Start Page: 1237
    End Page: 1245
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990
    Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=render
    Citation Count: 42
  • The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    2016
    Summary Details
    RESTRICTED
    Title: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    Author(s): Dilan Athauda, Thomas Foltynie
    Journal Name: Drug Discovery Today
    Publisher: Elsevier BV
    Vol: 21
    Issue #: 5
    Start Page: 802
    End Page: 818
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013
    Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013
    Citation Count: 246
  • Targeting the Dopaminergic System in Autoimmunity
    2019
    Summary Details
    RESTRICTED
    Title: Targeting the Dopaminergic System in Autoimmunity
    Author(s): Pía M. Vidal, Rodrigo Pacheco
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Vol: 15
    Issue #: 1
    Start Page: 57
    End Page: 73
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5
    Best OA location URL:
    Citation Count: 53
  • Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid
    2019
    Summary Details
    RESTRICTED
    Title: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid
    Author(s): Lorraine V. Kalia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 59
    Issue #:
    Start Page: 21
    End Page: 25
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016
    Best OA location URL:
    Citation Count: 16
  • Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    2023
    Summary Details
    RESTRICTED
    Title: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    Author(s): Viviana Brembati, Gaia Faustini, Francesca Longhena, Arianna Bellucci
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Vol: 16
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853
    Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdf
    Citation Count: 5
  • Small Molecules to Improve ER Proteostasis in Disease
    2019
    Summary Details
    RESTRICTED
    Title: Small Molecules to Improve ER Proteostasis in Disease
    Author(s): Vicente Gonzalez‐Teuber, Héctor Albert‐Gascó, Vincent C. Auyeung, Feroz R. Papa, Giovanna R. Mallucci, Claudio Hetz
    Journal Name: Trends in Pharmacological Sciences
    Publisher: Elsevier BV
    Vol: 40
    Issue #: 9
    Start Page: 684
    End Page: 695
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.tips.2019.07.003
    Best OA location URL: http://manuscript.elsevier.com/S0165614719301403/pdf/S0165614719301403.pdf
    Citation Count: 63
  • Clinical neurophysiology of Parkinson’s disease and parkinsonism
    2022
    Summary Details
    RESTRICTED
    Title: Clinical neurophysiology of Parkinson’s disease and parkinsonism
    Author(s): Robert Chen, Alfredo Berardelli, Amitabh Bhattacharya, Matteo Bologna, Kai‐Hsiang Stanley Chen, Alfonso Fasano, Rick C. Helmich, William D. Hutchison, Nitish Kamble, Andrea A. Kühn, Antonella Macerollo, Wolf‐Julian Neumann, Pramod Kumar Pal, Giulia Paparella, Antonio Suppa, Kaviraja Udupa
    Journal Name: Clinical Neurophysiology Practice
    Publisher: Elsevier BV
    Vol: 7
    Issue #:
    Start Page: 201
    End Page: 227
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002
    Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002
    Citation Count: 33
  • Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s
    2014
    Summary Details
    RESTRICTED
    Title: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s
    Author(s): Claire C. Meunier, Sohini Chowdhury, Lily Cappelletti, Todd Sherer
    Journal Name:
    Publisher:
    Vol:
    Issue #:
    Start Page: 22
    End Page: 27
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1
    Best OA location URL:
    Citation Count: 1
  • Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”
    2023
    Summary Details
    RESTRICTED
    Title: Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”
    Author(s): Corinne Morfill, Stanislava Pankratova, Pedro Machado, Nathalie K. Fernando, Anna Regoutz, Federica Talamona, Alessandra Pinna, Michał M. Kłosowski, Robert J. Wilkinson, Roland A. Fleck, Fei Xie, Alexandra E. Porter, Darya Kiryushko
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Vol: 15
    Issue #: 10
    Start Page: 13824
    End Page: 13824
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acsami.3c02300
    Best OA location URL: https://doi.org/10.1021/acsami.3c02300
    Citation Count: 0
  • Novel therapeutic approaches to target neurodegeneration
    2023
    Summary Details
    RESTRICTED
    Title: Novel therapeutic approaches to target neurodegeneration
    Author(s): Alerie Guzman de la Fuente, Silvia Pelucchi, Jérôme Mertens, Mónica Di Luca, Daniela Mauceri, Elena Marcello
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Vol: 180
    Issue #: 13
    Start Page: 1651
    End Page: 1673
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/bph.16078
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16078
    Citation Count: 7
  • Huntington disease: A quarter century of progress since the gene discovery
    2019
    Summary Details
    RESTRICTED
    Title: Huntington disease: A quarter century of progress since the gene discovery
    Author(s): Claudia Testa, Joseph Jankovic
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Vol: 396
    Issue #:
    Start Page: 52
    End Page: 68
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2018.09.022
    Best OA location URL:
    Citation Count: 59
  • REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.
    2014
    Summary Details
    RESTRICTED
    Title: REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.
    Author(s): Abhimanyu Mahajan, Liana S. Rosenthal, Charlene E. Gamaldo, Rachel E. Salas, Gregory M. Pontone, Arita McCoy, Chizoba C. Umeh, Zoltán Mari
    Journal Name:
    Publisher:
    Vol:
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.7916/d84b2zdf
    Best OA location URL:
    Citation Count: 4
  • Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
    2019
    Summary Details
    RESTRICTED
    Title: Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
    Author(s): Nicki Niemann, Joseph Jankovic
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 67
    Issue #:
    Start Page: 74
    End Page: 89
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.025
    Best OA location URL:
    Citation Count: 67
  • Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
    2011
    Summary Details
    RESTRICTED
    Title: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
    Author(s): Manfred Gerlach, Walter Maetzler, Karl Broich, Harald Hampel, L. Rems, Torsten Reum, Peter Riederer, Albrecht Stöffler, Johannes Streffer, Daniela Berg
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Vol: 119
    Issue #: 1
    Start Page: 39
    End Page: 52
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s00702-011-0682-x
    Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdf
    Citation Count: 68
  • Digital technologies: Innovations that transform the face of drug development
    2023
    Summary Details
    RESTRICTED
    Title: Digital technologies: Innovations that transform the face of drug development
    Author(s): Elena S. Izmailova, Bilal Abuasal, Hazem E. Hassan, Anindita Saha, Diane Stephenson
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Vol: 16
    Issue #: 8
    Start Page: 1323
    End Page: 1330
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.13533
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13533
    Citation Count: 2
  • Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update
    2017
    Summary Details
    RESTRICTED
    Title: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update
    Author(s): Philippe Huot, Véronique Sgambato‐Faure, Susan H. Fox, Andrew C. McCreary
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Vol: 8
    Issue #: 5
    Start Page: 973
    End Page: 986
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440
    Best OA location URL:
    Citation Count: 34
  • Unmet needs in Parkinson disease: Motor and non-motor
    2020
    Summary Details
    RESTRICTED
    Title: Unmet needs in Parkinson disease: Motor and non-motor
    Author(s): Peter A. LeWitt, K. Ray Chaudhuri
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 80
    Issue #:
    Start Page: S7
    End Page: S12
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024
    Best OA location URL: http://www.prd-journal.com/article/S1353802020307380/pdf
    Citation Count: 60
  • Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.
    2021
    Summary Details
    RESTRICTED
    Title: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.
    Author(s): Stefan Grathwohl, Emmanuel Quansah, Nazia Maroof, Jennifer A. Steiner, Liz Spycher, Fethalla Benmansour, Gonzalo Durán-Pacheco, Juliane Siebourg‐Polster, Krisztina Oroszlan-Szovik, Helga Remy, Markus Haenggi, Marc Stawiski, Matthias Selhausen, Pierre Mailver, Andreas Wolfert, Thomas Emrich, Zachary Madaj, Arel Su, Martha L. Escobar Galvis, Christoph Mueller, Annika Herrmann, Patrik Brundin, Markus Britschgi
    Journal Name:
    Publisher:
    Vol:
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326
    Best OA location URL:
    Citation Count: 7
  • γ‐Synuclein and the progression of cancer
    2007
    Summary Details
    RESTRICTED
    Title: γ‐Synuclein and the progression of cancer
    Author(s): Mushfika Ahmad, Samir Attoub, Maneesh N. Singh, Francis L. Martin, Omar M. A. El‐Agnaf
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Vol: 21
    Issue #: 13
    Start Page: 3419
    End Page: 3430
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.07-8379rev
    Best OA location URL:
    Citation Count: 91
  • Clinical and Imaging Markers of Prodromal Parkinson's Disease
    2020
    Summary Details
    RESTRICTED
    Title: Clinical and Imaging Markers of Prodromal Parkinson's Disease
    Author(s): Eldbjørg Hustad, Jan Aasly
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Vol: 11
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00395
    Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00395/pdf
    Citation Count: 91
  • Biomarkers for cognitive dysfunction in Parkinson's disease
    2018
    Summary Details
    RESTRICTED
    Title: Biomarkers for cognitive dysfunction in Parkinson's disease
    Author(s): Lorraine V. Kalia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 46
    Issue #:
    Start Page: S19
    End Page: S23
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.023
    Best OA location URL:
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.